Portal de Periódicos da CAPES

A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression

1993; American Psychiatric Association; Volume: 150; Issue: 1 Linguagem: Inglês

10.1176/ajp.150.1.118

1535-7228

Patrick J. McGrath, J W Stewart, Edward V. Nunes, Katja Ocepek‐Welikson, Judith G. Rabkin, F M Quitkin, D F Klein,

Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Back to table of contents Previous article Next article No AccessA double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depressionPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.150.1.118AboutSectionsView articleAbstractPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail View articleAbstractOBJECTIVE: Data from controlled studies concerning the response rates of patients to a second antidepressant medication after they have been unresponsive to a systematic trial of another antidepressant are extremely useful to clinicians for rational prescription of pharmacotherapy. Such information allows making an accurate prognosis, sustaining realistic hope in the patient, and achieving the best possible therapeutic outcome. This study was designed to add to the scanty literature available on this subject. METHOD: Eighty-nine mood- reactive, nonmelancholic, mainly chronically depressed outpatients at a university research clinic who were unresponsive to vigorous double- blind trials of imipramine or phenelzine were crossed over to treatment with the other drug under double-blind conditions. RESULTS: Of 46 patients previously unresponsive to imipramine who completed phenelzine treatment, 31 (67%) responded to phenelzine. Of 22 patients previously unresponsive to phenelzine who completed imipramine treatment, nine (41%) responded to imipramine. The difference in response rates was statistically significant. Even after they had shown no response to 7 weeks of placebo and 6 weeks of imipramine treatment, 10 (83%) of 12 patients who then completed treatment with phenelzine responded. CONCLUSIONS: These data suggest that among chronically ill, mood- reactive depressed patients with many symptoms of atypical depression, phenelzine is strikingly effective in those who have been nonresponders to imipramine and should be tried in such patients. Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited by70-year history of studying the effectiveness of therapy of patients with depression with antidepressants — irreversible nonselective monoamine oxidase inhibitorsZhurnal nevrologii i psikhiatrii im. S.S. Korsakova, Vol. 123, No. 1Monoamine Oxidase Inhibitors in Depressive Disorders5 November 2022Monoamine Oxidase Inhibitors in Depressive Disorders26 July 2021Relative Effectiveness of Monoamine Oxidase Inhibitor and Tricyclic Antidepressant Combination Therapy for Treatment-Resistant Depression30 October 2019 | Journal of Clinical Psychopharmacology, Vol. 39, No. 6Journal of Affective Disorders, Vol. 250Frontiers in Molecular Neuroscience, Vol. 11Frontiers in Neuroscience, Vol. 11Dépression résistante : les autres stratégies thérapeutiquesLa Presse Médicale, Vol. 45, No. 3Clinical PsychopharmacologyRoyal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders7 December 2015 | Australian & New Zealand Journal of Psychiatry, Vol. 49, No. 12Pharmacological approaches to the challenge of treatment-resistant depression1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 17, No. 2Drugs versus placebo for dysthymia18 June 2015 | Cochrane Database of Systematic Reviews, Vol. 13Expert Review of Clinical Pharmacology, Vol. 8, No. 6Neuropsychopharmacology, Vol. 39, No. 4Medical managementAtypical depressionMood disorder and headacheCNS Drugs, Vol. 27, No. 10Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease12 March 2010 | Molecular Neurodegeneration, Vol. 5, No. 1Selegiline transdermal system: a novel treatment option for major depressive disorder15 June 2009 | Expert Opinion on Pharmacotherapy, Vol. 10, No. 10Neuropsychopharmacology, Vol. 34, No. 13Acta Psychiatrica Scandinavica, Vol. 120, No. 3CNS Drugs, Vol. 23, No. 12Treatment of SSRI-Resistant Depression: A Meta-Analysis Comparing Within- Versus Across-Class SwitchesBiological Psychiatry, Vol. 63, No. 7AntidepressantsProgress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 31, No. 6Journal of the American Geriatrics Society, Vol. 55, No. 11Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation7 June 2006 | Neuropsychopharmacology, Vol. 31, No. 11European Neuropsychopharmacology, Vol. 16, No. 6Psychiatry Research, Vol. 141, No. 1CNS Spectrums, Vol. 11, No. 5Psychotherapy and Psychosomatics, Vol. 75, No. 3Monoaminergic‐based Pharmacotherapy for Depression29 January 2008Journal of Affective Disorders, Vol. 89, No. 1-3CNS Spectrums, Vol. 9, No. 11Journal of Psychiatric Practice, Vol. 10, No. 4Psychopharmacology: Underuse of Evidence-Based Pharmacotherapies for Affective DisordersMegan Dwight-Johnson, M.D., M.P.H., Isabel T. Lagomasino, M.D., and George M. Simpson, M.D.1 August 2003 | Psychiatric Services, Vol. 54, No. 8Psychiatric Clinics of North America, Vol. 26, No. 2Biological Psychiatry, Vol. 52, No. 6Strategies for Treatment Refractory Depression30 June 2016 | Journal of Pharmacy Practice, Vol. 14, No. 6Monoamine Oxidase Inhibitors RevisitedPsychiatric Annals, Vol. 31, No. 6Validity of Clinical Trials of AntidepressantsFrederic M. Quitkin, M.D., Judith G. Rabkin, Ph.D., Jessica Gerald, B.A., John M. Davis, M.D., and Donald F. Klein, M.D.1 March 2000 | American Journal of Psychiatry, Vol. 157, No. 3, Vol. 14Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines1 July 2016 | Journal of Psychopharmacology, Vol. 14, No. 1Biological Psychiatry, Vol. 44, No. 9Research and Clinical Strategies for Treatment Resistant Depression: Buyer Beware!29 June 2016 | Journal of the American Psychiatric Nurses Association, Vol. 3, No. 1Journal of Clinical Psychopharmacology, Vol. 17International Journal of Psychiatry in Clinical Practice, Vol. 1, No. 4MANAGEMENT OF TREATMENT-RESISTANT UNIPOLAR AND CHRONICALLY DEPRESSED PATIENTSPsychiatric Clinics of North America, Vol. 19, No. 2Journal of Neural Transmission, Vol. 103, No. 1-2Journal of Affective Disorders, Vol. 36, No. 3-4Comprehensive Psychiatry, Vol. 37, No. 6Recent Developments in Geriatric Psychopharmacotherapy1 October 1994 | The Canadian Journal of Psychiatry, Vol. 39, No. 8_supplThe Utility of Guidelines and Algorithms for PracticePsychiatric Annals, Vol. 24, No. 7Depression, Vol. 2, No. 1Journal of Affective Disorders, Vol. 30, No. 3British Journal of Psychiatry, Vol. 165, No. S26Atypical Depression: A Valid Clinical Entity?Psychiatric Clinics of North America, Vol. 16, No. 3Chronic DepressionRobert H. Howland1 April 2006 | Psychiatric Services, Vol. 44, No. 7International Journal of Mental Health, Vol. 22, No. 2 Volume 150Issue 1 January 1993Pages 118-123 Metrics PDF download History Published online 1 April 2006 Published in print 1 January 1993